相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Small Molecule Inhibitors of Protein Kinase D: Early Development, Current Approaches, and Future Directions
Qiming Jane Wang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2023)
Hematopoietic Progenitor Kinase 1 in Tumor Immunology: A Medicinal Chemistry Perspective
Qiangsheng Zhu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2022)
Effective treatment of alopecia universalis with oral upadacitinib
Soundos Youssef et al.
JAAD Case Reports (2022)
Discovery of BMS-986202: A Clinical Tyk2 Inhibitor that Binds to Tyk2 JH2
Chunjian Liu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
Discovery and Biological Evaluation of N-Methyl-pyrrolo[2,3-b]pyridine-5-carboxamide Derivatives as JAK1-Selective Inhibitors
Eunsun Park et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
Discovery of BPR1R024, an Orally Active and Selective CSF1R Inhibitor that Exhibits Antitumor and Immunomodulatory Activity in a Murine Colon Tumor Model
Kun-Hung Lee et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
Selective inhibition of JAK3 signaling is sufficient to reverse alopecia areata
Zhenpeng Dai et al.
JCI INSIGHT (2021)
AutoDock Vina 1.2.0: New Docking Methods, Expanded Force Field, and Python Bindings
Jerome Eberhardt et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2021)
The JAK/STAT signaling pathway: from bench to clinic
Xiaoyi Hu et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)
Oral ritlecitinib and brepocitinib in patients with Moderate to Severe Active Ulcerative Colitis: Data from the VIBRATO umbrella study
W. Sandborn et al.
JOURNAL OF CROHNS & COLITIS (2021)
Synthesis and biological evaluation of novel pyrazolo[1,5-a]pyrimidines: Discovery of a selective inhibitor of JAK1 JH2 pseudokinase and VPS34
Justin D. Singleton et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2020)
The role of JAK/STAT signaling pathway and its inhibitors in diseases
Ping Xin et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2020)
Janus kinases (JAKs): The efficient therapeutic targets for autoimmune diseases and myeloproliferative disorders
Pengfei Xu et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
Discovery of (2R)-N-[3-[2-[(3-Methoxy-1-methyl-pyrazol-4-yl)amino]pyrimidin-4-yl]-1H-indol-7-yl]-2-(4-methylpiperazin-1-yl)propenamide (AZD4205) as a Potent and Selective Janus Kinase 1 Inhibitor
Qibin Su et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Fragment-Based Discovery of Pyrazolopyridones as JAK1 Inhibitors with Excellent Subtype Selectivity
Bettina Borreschmidt Hansen et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
JAK selectivity: more precision less troubles
Giulia Roda et al.
EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY (2020)
Identification of N-{cis-3-(Methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)aminolcyclobutyl}propane-1-sulfonamide (PF-04965842): A Selective JAK1 Clinical Candidate for the Treatment of Autoimmune Diseases
Michael L. Vazquez et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Dual Inhibition of TYK2 and JAK1 for the Treatment of Autoimmune Diseases: Discovery of ((S)-2,2-Difluorocyclopropyl)((1R,5S)-3-(2-(1-methyl-1H-pyrazol-4-yl)amino)pyrimidin-4-yl)-3,8-diazabicyclo[3.2.1]octan-8-yl)methanone (PF-06700841)
Andrew Fensome et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
The Discovery of 3-((4-Chloro-3-methoxyphenyl)amino)-1-((3R,4S)-4-cyanotetrahydro-2H-pyran-3-yl)-1H-pyrazole-4-carboxamide, a Highly Ligand Efficient and Efficacious Janus Kinase 1 Selective Inhibitor with Favorable Pharmacokinetic Properties
Tony Siu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
A novel JAK inhibitor, peficitinib, demonstrates potent efficacy in a rat adjuvant-induced arthritis model
Misato Ito et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2017)
The Janus Kinase (JAK) FERM and SH2 Domains: Bringing Specificity to JAK-Receptor Interactions
Ryan Ferrao et al.
FRONTIERS IN ENDOCRINOLOGY (2017)
Doxorubicin: nanotechnological overviews from bench to bedside
Maximiliano Cagel et al.
DRUG DISCOVERY TODAY (2017)
Design and Synthesis of Janus Kinase 2 (JAK2) and Histone Deacetlyase (HDAC) Bispecific Inhibitors Based on Pacritinib and Evidence of Dual Pathway Inhibition in Hematological Cell Lines
Eugene Guorong Yang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Efficacy and Safety of ABT-494, a Selective JAK-1 Inhibitor, in a Phase IIb Study in Patients With Rheumatoid Arthritis and an Inadequate Response to Methotrexate
Mark C. Genovese et al.
ARTHRITIS & RHEUMATOLOGY (2016)
Safety and efficacy of the JAK inhibitor tofacitinib citrate in patients with alopecia areata
Milene Kennedy Crispin et al.
JCI INSIGHT (2016)
Oral ruxolitinib induces hair regrowth in patients with moderate-to-severe alopecia areata
Julian Mackay-Wiggan et al.
JCI INSIGHT (2016)
The JAK-STAT Pathway: Impact on Human Disease and Therapeutic Intervention
John J. O'Shea et al.
ANNUAL REVIEW OF MEDICINE, VOL 66 (2015)
Structure activity optimization of 6H-pyrrolo[2,3-e][1,2,4]triazolo[4,3-a]pyrazines as Jak1 kinase inhibitors
Michael Friedman et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2015)
Pharmacokinetics and Pharmacokinetic/Pharmacodynamic Modeling of Filgotinib (GLPG0634), a Selective JAK1 Inhibitor, in Support of Phase IIB Dose Selection
Florence Namour et al.
CLINICAL PHARMACOKINETICS (2015)
Benzimidazole Derivatives as Potent JAK1-Selective Inhibitors
Mi Kyoung Kim et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Pharmacologic inhibition of JAK-STAT signaling promotes hair growth
Sivan Harel et al.
SCIENCE ADVANCES (2015)
VX-509 (Decernotinib) Is a Potent and Selective Janus Kinase 3 Inhibitor That Attenuates Inflammation in Animal Models of Autoimmune Disease
Sudipta Mahajan et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2015)
Design and Synthesis of Tricyclic JAK3 Inhibitors with Picomolar Affinities as Novel Molecular Probes
Matthias Gehringer et al.
CHEMMEDCHEM (2014)
Systematic Review of Tofacitinib: A New Drug for the Management of Rheumatoid Arthritis
Kirandeep Kaur et al.
CLINICAL THERAPEUTICS (2014)
Triazolopyridines as Selective JAK1 Inhibitors: From Hit Identification to GLPG0634
Christel J. Menet et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Discovery and Development of Janus Kinase (JAK) Inhibitors for Inflammatory Diseases
James D. Clark et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition
Luzhou Xing et al.
NATURE MEDICINE (2014)
An Improved and Efficient Process for the Preparation of Tofacitinib Citrate
Yogesh S. Patil et al.
ORGANIC PROCESS RESEARCH & DEVELOPMENT (2014)
Identification of C-2 Hydroxyethyl Imidazopyrrolopyridines as Potent JAK1 Inhibitors with Favorable Physicochemical Properties and High Selectivity over JAK2
Mark Zak et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Back to the future: oral targeted therapy for RA and other autoimmune diseases
John J. O'Shea et al.
NATURE REVIEWS RHEUMATOLOGY (2013)
Hair and scalp dermatoscopy
Mariya Miteva et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2012)
Ruxolitinib: a potent and selective Janus kinase 1 and 2 inhibitor in patients with myelofibrosis. An update for clinicians
Claire Harrison et al.
THERAPEUTIC ADVANCES IN HEMATOLOGY (2012)
Molecular basis of androgenetic alopecia: From androgen to paracrine mediators through dermal papilla
Shigeki Inui et al.
JOURNAL OF DERMATOLOGICAL SCIENCE (2011)
Janus kinase inhibitors for the treatment of myeloproliferative neoplasias and beyond
Alfonso Quintas-Cardama et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
Software News and Update AutoDock Vina: Improving the Speed and Accuracy of Docking with a New Scoring Function, Efficient Optimization, and Multithreading
Oleg Trott et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2010)
Selective Inhibition of JAK1 and JAK2 Is Efficacious in Rodent Models of Arthritis: Preclinical Characterization of INCB028050
Jordan S. Fridman et al.
JOURNAL OF IMMUNOLOGY (2010)
Discovery of CP-690,550: A Potent and Selective Janus Kinase (JAK) Inhibitor for the Treatment of Autoimmune Diseases and Organ Transplant Rejection
Mark E. Flanagan et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Structural and Thermodynamic Characterization of the TYK2 and JAK3 Kinase Domains in Complex with CP-690550 and CMP-6
Jill E. Chrencik et al.
JOURNAL OF MOLECULAR BIOLOGY (2010)
Dissecting Specificity in the Janus Kinases: The Structures of JAK-Specific Inhibitors Complexed to the JAK1 and JAK2 Protein Tyrosine Kinase Domains
Neal K. Williams et al.
JOURNAL OF MOLECULAR BIOLOGY (2009)
Efficacy of TG101348, a selective JAK2 inhibitor, in treatment of a murine model of JAK2V617F-induced polycythemia vera
Gerlinde Werning et al.
CANCER CELL (2008)
Discovery and metabolic stabilization of potent and selective 2-amino-N-(adamant-2-yl) acetamide 11β-hydroxysteroid dehydrogenase type 1 inhibitors
Jeffrey J. Rohde et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
Jaks and cytokine receptors - An intimate relationship
Claude Haan et al.
BIOCHEMICAL PHARMACOLOGY (2006)
A comprehensive guide for the accurate classification of murine hair follicles in distinct hair cycle stages
S Müller-Röver et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2001)
Treatments for androgenetic alopecia and alopecia areata - Current options and future prospects
VM Meidan et al.
DRUGS (2001)
分享论文
